ARCHIVES

Mammography Hazard In ACS-NCI Screening Charged

This article is from The Cancer Letter archive.

Vol. 01 No. 42 | October 17, 1975

Download PDF Visit The Full Archive

Related Articles

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

November 14, 2003

Cancer death rate dropping 1.1 percent a year, annual report finds.

October 7, 2005

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

June 20, 1975

In Aftermath of NEJM Article, Critic Bailar Declares The Defeat Of Cancer Treatment

June 6, 1997

Center Core Grants Could Face Cuts Of Up To 20%

February 16, 1990

Pastan’s Laboratory Creates “Chimeric” Monoclonal Antibody With Human, Muse

August 12, 1988